Blog

Aug 9, 2023

Frequency Change: Korro Bio Edits Its Message, Rewrites Its Future with Reverse Merger

Posted by in categories: biotech/medical, futurism

Korro Bio plans a reverse merger with Frequency Therapeutics to fund clinical studies of its lead candidate, designed to treat alpha-1 antitrypsin deficiency (AATD) in the liver.

Comments are closed.